Skip to main content
Image
CKM logo reversed
CKM
Cardiology Vascular Medical Education
Register for free Log in
Cardiovascular • Kidney • Metabolic
Lifelong learning for healthcare professionals
CVRM banner
CVRM banner

Home

About

About Us Advisory Board

Topics

View AllChronic Kidney DiseaseDiabetesCardiovascular Co-morbiditiesMetabolic Dysfunction-associated Fatty Liver Disease (MAFLD)Obesity

Content type

Videos Articles Broadcasts Podcasts News

Faculty

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z View All

Events

Upcoming Events Radcliffe Events All Events

Resource Hubs

Inflammatory Risk in CVD Rise of CVRM
  • Content for healthcare professionals only
Image
CKM logo
Register for free Log in
Back to Main Menu

View all platforms

Cardiology Vascular CKM Medical Education
  • Content for healthcare professionals only

Breadcrumb

  • Home /
  • News Index

Latest News

Albuminuria Change Validated as CKD Surrogate Endpoint
Written by: Radcliffe CVRM
Albuminuria Change Validated as CKD Surrogate Endpoint
12 November 2025
Balcinrenone Plus Dapagliflozin Cuts Albuminuria in CKD
Written by: Radcliffe CVRM
Balcinrenone Plus Dapagliflozin Cuts Albuminuria in CKD
12 November 2025
Semaglutide Improves PAD Outcomes Regardless of Sex
Written by: Radcliffe CVRM
Semaglutide Improves PAD Outcomes Regardless of Sex
12 November 2025
Tirzepatide and Semaglutide: Comparable CV Outcomes
Written by: Radcliffe CVRM
Tirzepatide and Semaglutide: Comparable CV Outcomes
12 November 2025
Pemvidutide for MASH: IMPACT Trial 24-Week Results
Written by: Radcliffe CVRM
Pemvidutide for MASH: IMPACT Trial 24-Week Results
12 November 2025
Fish Oil Cuts CV Events in Haemodialysis Patients
Written by: Radcliffe CVRM
Fish Oil Cuts CV Events in Haemodialysis Patients
12 November 2025
BMI Affects NT-proBNP Risk Stratification in HFpEF
Written by: Radcliffe Cardiology
BMI Affects NT-proBNP Risk Stratification in HFpEF
12 November 2025
Eloralintide Shows Significant Weight Loss in Phase 2 Trial
Written by: Radcliffe CVRM
Eloralintide Shows Significant Weight Loss in Phase 2 Trial
12 November 2025
New BP Guideline Adopts PREVENT Risk Assessment
Written by: Radcliffe Cardiology
New BP Guideline Adopts PREVENT Risk Assessment
30 October 2025
MC4R Deficiency: Obesity with Lower CVD Risk?
Written by: Radcliffe CVRM
MC4R Deficiency: Obesity with Lower CVD Risk?
22 October 2025
  • Load More

External news

Written by: Cardiac Vascular News
Catheter Precision Announces Accepted Publication in Leading European Medical Journal
13 April 2026
Written by: Medscape
Long COVID May Increase Your Heart Disease Risk
13 April 2026
Written by: Cardiac Vascular News
Bracco Affirms ASNC Position Statement Elevating Cardiac PET with Myocardial Blood Flow as Preferred Standard for Coronary Artery Disease
13 April 2026
Written by: Medscape
Exercise Intensity Over Volume Linked to Lower Disease Risks
13 April 2026
Written by: Medscape
The Flaws in the New HHS Nutrition Education Initiative
10 April 2026
Written by: Medscape
Apr 10 2026 This Week in Cardiology
10 April 2026
Written by: Cardiovascular Business
FDA clears new AI model for detecting signs of cardiac amyloidosis
10 April 2026
Written by: Cardiovascular Business
PVL after TTVR linked to much lower survival rate, fewer clinical benefits
10 April 2026
Written by: Medscape
Medscape Physician Compensation Report 2026: Positive Signs
10 April 2026
Written by: Cardiovascular Business
SVS quality initiative gathers data to improve vascular care
10 April 2026
  • Load More

Footer Menu 1

  • About Us
  • Our team
  • Privacy
  • Terms & Conditions
  • Contact Us
  • Radcliffe Events
  • Radcliffe Group

Footer Menu 2

  • Authors A-Z
  • Image gallery
  • Industry Partners
  • Media Partners
  • Services
  • Promotional Opportunities

Quick Links 1

  • Heart Failure
  • Standards and Guidelines

Quick Links 2

  • Prevention and Chronic Conditions
  • Rise of CVRM
Register for FREE
CKM Logo

Copyright® 2026 Radcliffe Medical Media. All rights reserved.

Published content on this site is for information purposes and is not a substitute for professional medical advice. Where views/opinions are expressed, they are those of the author(s) and not of Radcliffe Medical Media.

Radcliffe Cardiology is part of Radcliffe Medical Media, an independent publisher and the Radcliffe Group Ltd. It is not affiliated with or is an agent of, the Oxford Heart Centre, the John Radcliffe Hospital or the Oxford University Hospitals NHS Foundation Trust group.